Symbol="ADMP"
AssetType="Common Stock"
Name="Adamis Pharma"
Description="Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California."
CIK="887247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2846200"
EBITDA="-22324544"
PERatio="None"
PEGRatio="0"
BookValue="-4.071"
DividendPerShare="0"
DividendYield="0"
EPS="-11.33"
RevenuePerShareTTM="2.348"
ProfitMargin="0"
OperatingMarginTTM="-4.664"
ReturnOnAssetsTTM="-0.744"
ReturnOnEquityTTM="-7.85"
RevenueTTM="5054600"
GrossProfitTTM="-1431408"
DilutedEPSTTM="-11.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.259"
AnalystTargetPrice="0.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="8.62"
EVToRevenue="15.59"
EVToEBITDA="-0.784"
Beta="1.208"
num_52WeekHigh="26.18"
num_52WeekLow="0.77"
num_50DayMovingAverage="1.898"
num_200DayMovingAverage="8.33"
SharesOutstanding="2790400"
DividendDate="None"
ExDividendDate="None"
symbol="ADMP"
open="0.98"
high="0.98"
low="0.82"
price="0.89"
volume="756386.00"
latest_trading_day="2023-08-18"
previous_close="1.02"
change="-0.13"
change_percent="-12.4902%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="1"
Volume_recent_avg="1969364"
Change_recent_avg="0.01"
Delta_recent_avg="0.22"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-2.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="1108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_negative_thumbnail_id_2="139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="639"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0069.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
